Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Multi-drug resistant infections medicine 'Zaynich' to get USFDA approval next year: Wockhardt Chairman

Ruchika Sharma14 April 2025 3:49 PM IST

Dubai: Zaynich, a multi-drug resistant infections medicine, is set to receive the US Food and Drug Administration (USFDA) approval in 2026,...

Sandoz to acquire Just-Evotec Biologics EU SAS in-house development, manufacturing capabilities in France for USD 300 million

Arthritis drug: Sandoz files US antitrust litigation against Amgen

Ruchika Sharma14 April 2025 2:30 PM IST

Sandoz is seeking an injunction to prevent Amgen from using certain patent rights to block biosimilar competition and allow Sandoz to launch Erelzi.

Sun Pharma, Zydus and Glenmark recall various products in US over manufacturing issues

Ruchika Sharma14 April 2025 1:30 PM IST

Sun Pharma, Zydus, and Glenmark are recalling various products in the US market due to manufacturing-related concerns, the US health regulator...

Roche announces topline results from trials investigating astegolimab compared to placebo in COPD patients

Roche Columvi gets European Commission nod as bispecific antibody for diffuse large B-cell lymphoma after initial therapy

Ruchika Sharma14 April 2025 12:30 PM IST

Basel: Roche has announced that the company has received approval from the European Commission for Columvi (glofitamab) in...

Zydus Lifesciences bags USFDA okay for arthritis drug Celecoxib

Aurobindo Pharma gets USFDA final, tentative nod for different strengths of deep vein thrombosis drug Rivaroxaban

Ruchika Sharma14 April 2025 11:30 AM IST

Aurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and...

US tariffs on pharma sector would be counterproductive for Americans, says Wockhardt Chairman

Ruchika Sharma13 April 2025 3:15 PM IST

Wockhardt Chairman Habib Khorakiwala said that U.S. tariffs on pharmaceutical products would ultimately be counterproductive for Americans.The U.S....

CDSCO Panel Asks Novartis to Submit Revised Protocol, Dose Changes for Ianalumab Phase III Trial

Novartis plans to invest USD 23 billion over next 5 years in US based infrastructure

Ruchika Sharma13 April 2025 12:30 PM IST

East Hanover: Novartis, a global medicines company, has announced a planned USD 23 billion investment over 5 years in US-based infrastructure,...

CDSCO Panel Approves Phase IV Protocol Amendment for Bristol-Myers Squibbs Mavacamten Study

Pomalyst monopoly case: Bristol Myers wins dismissal of lawsuit

Ruchika Sharma13 April 2025 11:00 AM IST

A federal judge in New York has dismissed a proposed class action against pharmaceutical giant Bristol Myers Squibb, which accused the company of...

Morepen Labs plans to employ over 1000 professionals

Ruchika Sharma12 April 2025 1:52 PM IST

Gurugram: Morepen Laboratories Ltd. has announced the addition of more than 1,000 professionals to its salesforce over the next three years,...

Raid at quack clinic in Telangana, drugs including Amoxycillin seized

Ruchika Sharma12 April 2025 12:33 PM IST

Telangana: Drugs Control Administration, Telangana raided a quack's clinic in Medaram Village, Tadvai Mandal, Mulugu District and seized drugs...

Zydus Lifesciences receives tentative approval from USFDA for Chronic lymphocytic leukaemia drug Ibrutinib

Zydus Lifesciences bags USFDA nod for Duchenne muscular dystrophy drug Jaythari

Ruchika Sharma12 April 2025 11:30 AM IST

Ahmedabad: Pharma major, Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA)...

Granules India arm gets 1 USFDA observation for Hyderabad facility

Aurobindo Pharma arm gets 11 USFDA observations for Raleigh Plant

Ruchika Sharma11 April 2025 5:46 PM IST

Hyderabad: Aurobindo Pharma has announced that the United States Food and Drug Administration (USFDA) has issued 11 observations after an...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok